Mon, Jan 26, 2015, 11:15 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • shawnsean37 shawnsean37 Apr 3, 2013 1:19 AM Flag

    how long will it take AutoDesk to complete their software for the bioprinter?

    Anyone have experience with this kind of computer programming task? Any software engineers out there?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If they are automating the current features of the printer I'd guesstimate a year. If they are trying to incorporate and accommodate ongoing emerging learnings, who knows? I would put that at the level of 2 - 10 million lines of code. Think F-22 or national power grid. I'm betting they're going to do this first option and take a stab at allowing the code to be easily modified to adapt to emerging learnings. These are my thoughts which clearly demonstrate that " I don't know" :-)

    • I guess no computer science guys are out there

      • 1 Reply to shawnsean37
      • I cannot give you the answer you want, but an interesting cut & paste from a web article may give us a clue as to what they are attempting to do with the software. Forgive me if this article has already been shared on this board.

        It comes from http://techcrunch.com/2012/12/17/organovo-autocad/ and is as follows:

        “This could give us power to recreate human tissues and organs outside of the body, but you still have to build blood vessels and you need fairly intricate designs,” said Keith Murphy, the company’s CEO.

        As those designs become more intricate, the company’s management realized there would be a need for design software. Organovo could have gone down this path alone, but the company’s management realized that having an experienced partner like Autodesk might help.

        Autodesk, a company with a $7.8 billion market cap that builds software for product designers, architects, animators and more, has a small, but growing team focused on bio and nano-programmable matter. The 14-person team partners with researchers at universities like UC Berkeley on synthetic biology projects.

        “In a sense, it’s like a little startup inside of a much larger company,” said Carlos Olguin, who is part of the research group at Autodesk. --------- End of Paste -------

        My guess is that they are attempting to design tissue with the problematic blood vessels neatly incorporated.

 
ONVO
6.75+0.43(+6.80%)Jan 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.